An almost exclusive association of the numerous investigated inflammatory biomarkers with delirium offers room for and discussion on a novel approach: The implementation of a widely used inflammatory marker (i.e., CRP or procalcitonin) as a diagnostic tool might help facilitate diagnosis of hypoactive delirium. This evidence concerns the gene CRP and delirium.